Egypt vs Poland: The number of people with susceptibility test result for rifampicin
Egypt
2,962
in 2021
Poland
2,415
in 2021
Egypt rank
41st
Poland rank
43rd
The number of people with susceptibility test result for rifampicin over time
- Egypt
- Poland
How they compare
Egypt currently reports 2,962 against 2,415 in Poland, a difference of 547.
That makes Egypt's figure about 1.2 times Poland's.
The two have swapped places 1 time across 5 shared years of data; in 2017 it was Poland ahead.
Egypt ranks 41st and Poland ranks 43rd of 155 countries.
Across the 2 decades both report, Egypt averaged higher in 1 and Poland in 1.
Head to head by decade
| Decade | Egypt | Poland | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2,475 | 3,229 | 753.67 | Poland |
| 2020s | 2,888 | 2,216 | 672.5 | Egypt |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Egypt or Poland?
- Egypt, at 2,962 against 2,415 in Poland as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Egypt and Poland?
- 547, with Egypt ahead.
- How many years of comparable data are there for Egypt and Poland?
- 5 years are reported by both, from 2017 to 2021.
- How do Egypt and Poland rank globally for the number of people with susceptibility test result for rifampicin?
- Egypt ranks 41st and Poland ranks 43rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.